| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 09/02/2010 | US20100221761 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
| 09/02/2010 | US20100221368 Methods for Inhibiting Cytokines |
| 09/02/2010 | US20100221362 Stable amorphous calcium carbonate comprising synthetic phosphorylated peptides |
| 09/02/2010 | US20100221347 Enhancing solute transport within a tissue scaffold |
| 09/02/2010 | US20100221345 Osteogenic biomaterial containing osteogenesis promoting substance and nanogel |
| 09/02/2010 | US20100221340 Method and compositions for treatment or prevention of inflammatory conditions |
| 09/02/2010 | US20100221337 Method of treating arthritis, pain or inflammation with naproxen 2(methanesulfonyl)ethyl ester and an h2 receptor antagonist |
| 09/02/2010 | US20100221336 Method of treating arthritis, pain or inflammation with naproxen 2(methanesulfonyl)ethyl ester and a proton pump inhibitor |
| 09/02/2010 | US20100221331 Pharmaceutical compositions comprising colloidal silicon dioxide |
| 09/02/2010 | US20100221330 Buoyant formulations of betaine |
| 09/02/2010 | US20100221305 Formulations for coated microprojections containing non-volatile counterions |
| 09/02/2010 | US20100221302 Delivery System For Heparin-Binding Growth Factors |
| 09/02/2010 | US20100221263 Anti-Sclerostin Antibodies |
| 09/02/2010 | US20100221257 Binding members-513 |
| 09/02/2010 | US20100221252 Mdl-1 uses |
| 09/02/2010 | US20100221234 Bone delivery conjugates and method of using same to target proteins to bone |
| 09/02/2010 | US20100221232 Composition and methods for osteogenic gene therapy |
| 09/02/2010 | US20100221229 Modulating bone growth in treating scoliosis |
| 09/02/2010 | US20100221221 N-phenyl-2-pyrimidineamine derivatives |
| 09/02/2010 | US20100221210 Dimeric Alpha Interferon PEGylated Site-Specifically Shows Enhanced and Prolonged Efficacy in Vivo |
| 09/02/2010 | US20100221179 IL-1 Binding Proteins |
| 09/02/2010 | CA2753604A1 Drug combinations containing pde4-inhibitors and nsaids |
| 09/02/2010 | CA2753597A1 Drug combinations containing pde4-inhibitors and nsaids |
| 09/02/2010 | CA2752485A1 Process for producing phenyl-substituted heterocyclic derivative through coupling using transition metal catalyst |
| 09/01/2010 | EP2223922A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 09/01/2010 | EP2223688A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of Using and Compositions Thereof |
| 09/01/2010 | EP2223687A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of Using and Compositions Thereof |
| 09/01/2010 | EP2222704A1 14-3-3 eta antibodies and uses thereof for the diagnosis and treatment of arthritis |
| 09/01/2010 | EP2222328A1 Method of administering conjugates |
| 09/01/2010 | EP2222277A1 Pegylated liposomal formulations for photodynamic treatment of inflammatory diseases |
| 09/01/2010 | EP2022788B1 Novel crystal of 3-[5-[4-(cyclopentyloxy)-2- hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6-yl)methoxy]phenyl]propionic acid |
| 09/01/2010 | EP1854787B1 Novel cyclic compound having quinolylalkylthio group |
| 09/01/2010 | EP1845092B1 Pyrimidinone compounds, their preparation and use thereof |
| 09/01/2010 | EP1635839B1 Benzo[4,5]thieno[2,3-d]pyrimidin-4-ones and their use in therapy |
| 09/01/2010 | EP1583525B1 Use of porphyrin synthesis substances in combination with salicylates and antioxidants for use in phototherapy to cure skin and articulation diseases |
| 09/01/2010 | EP1430027B1 Novel aminoazetidine, -pyrrolidine and -piperidine derivatives |
| 09/01/2010 | EP1423406B1 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina) |
| 09/01/2010 | EP1408117B1 Glycoprotein and process for producing the same |
| 09/01/2010 | EP1379508B1 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
| 09/01/2010 | EP1207905B1 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents |
| 09/01/2010 | EP1028942B1 Dipeptide nitriles |
| 09/01/2010 | CN201564118U Pillow for placing auxiliary substance |
| 09/01/2010 | CN1943651B A medicinal composition for treating gout |
| 09/01/2010 | CN1938018B Use of compounds for the preparation of a therapeutical composition for treatment of various disease states associated with a reduced igf-1 serum level |
| 09/01/2010 | CN101821291A Compositions and methods for use for antibodies against sclerostin |
| 09/01/2010 | CN101821283A Use of SLIT, NEPHRIN, ephrin or semaphorin for treatment of cartilage diseases |
| 09/01/2010 | CN101821235A Pyrrolidin-2 -one derivatives as androgen receptor modulator |
| 09/01/2010 | CN101820914A Prophylactic or therapeutic agent for inflammatory disease comprising thymidine phosphorylase inhibitor as active ingredient |
| 09/01/2010 | CN101817872A Orally administered peptides synergize statin activity |
| 09/01/2010 | CN101817801A Preparation method of new crystal form K of 2-(3-cyano-4-isobutoxy)-4-methyl-5-thiazole formic acid and other crystal forms |
| 09/01/2010 | CN101817798A Novel environment-friendly process for preparing leflunomide |
| 09/01/2010 | CN101816819A Multifunctional saline-alkaline heat transfer treatment waistband and preparation method thereof |
| 09/01/2010 | CN101816818A Multifunctional saline-alkaline heat transfer treatment chair and preparation method thereof |
| 09/01/2010 | CN101816780A Injectable bone growth factor-carrying microspheres and preparation method thereof |
| 09/01/2010 | CN101816760A Chinese medicament for treating rheumatoid disease |
| 09/01/2010 | CN101816729A Medicament for treating arthritis and preparation method thereof |
| 09/01/2010 | CN101816728A Chinese medicinal composition for treating femoral head necrosis and preparation method thereof |
| 09/01/2010 | CN101816720A Bonesetting and collaterals activating pills |
| 09/01/2010 | CN101816718A Method for producing Dafeng pills for treating low back pain by utilizing micro-powder technology |
| 09/01/2010 | CN101816714A Chinese traditional medicine for promoting fracture healing and preparation method thereof |
| 09/01/2010 | CN101816713A Garden balsam stem pain-relieving paste |
| 09/01/2010 | CN101816708A Chinese medicinal composition for curing rheumatism and preparation method thereof |
| 09/01/2010 | CN101816705A Medicine for treating femoral head necrosis by three-needle injection and fumigation and preparation method thereof |
| 09/01/2010 | CN101816637A Leflunomide tablet preparation and preparation method thereof |
| 09/01/2010 | CN101816634A Technology for preparing bone growth factor carrying microsphere by using ultrasonic atomization method |
| 09/01/2010 | CN101816630A Uricase lipid nanoparticle and preparation method thereof |
| 09/01/2010 | CN101816626A Pharmaceutical compositions and dosage forms of thalidomide |
| 09/01/2010 | CN101254291B Medicament for curing cervical vertigo |
| 09/01/2010 | CN101254284B Rheumatism treating medicine combination, preparation and quality control method |
| 09/01/2010 | CN101229356B External wad for treating cervical spondylosis |
| 09/01/2010 | CN101204533B Yaotuhuiwei capsule combining anti-walk for prolapse of lumbar intervertebral disc |
| 09/01/2010 | CN101181557B Chinese medicine composition for curing ankylosing spondylitis, rheumatism and rheumatoid as well as method of making the same |
| 09/01/2010 | CN101099846B Detumescence pain-relieving Babu plaster and preparing method |
| 09/01/2010 | CN101041012B Compound Chinese traditional medicine for creating bone joint ligament loosing and dislocation |
| 08/31/2010 | US7786321 Compounds of the N-acylamino amide family compositions comprising them and uses thereof |
| 08/31/2010 | US7786177 Phenylalanine enamide derivatives |
| 08/31/2010 | US7786135 Substituted pyrroline kinase inhibitors |
| 08/31/2010 | US7786132 1-(2-{4-[5-(2-Azetidin-1-yl-ethoxy)-benzo[b]thiophen-2-y1]-5-bromo-pyrimidin-2-ylamino}-ethyl)-5,5-dimethyl-imidazolidine-2,4-dione, useful for treating diseases mediated by polo-like kinase, selected from rheumatoid arthritis and breast cancer, in a mammals; antiproliferative agents |
| 08/31/2010 | US7786048 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 08/31/2010 | US7785873 Antigen arrays for treatment of bone disease |
| 08/31/2010 | US7785838 Variants of mammalian prolactin, prolactin receptor antagonists, and methods of use |
| 08/31/2010 | US7785835 A protein complex which includes a growth factor, growth factor binding protein and vitronectin; for treating cancers, psoriasis, atherosclerosis and wounds prone to hypertrophic scarring |
| 08/31/2010 | US7785819 Diagnosis of autoimmune disease; generate solid support, incubate with fluid sample, detect preferential antigens, compare to control, evaluate for autoimmune diseases |
| 08/31/2010 | US7785599 Albumin fusion proteins |
| 08/31/2010 | CA2569861C Pyrrolidine derivatives as ccr5 antagonists |
| 08/31/2010 | CA2389545C Chemokine receptor binding heterocyclic compounds |
| 08/31/2010 | CA2332817C Il-6 antagonist peptides |
| 08/26/2010 | WO2010095663A1 Fused heterocyclic ring compound |
| 08/26/2010 | WO2010095270A1 Anti-human α9 integrin antibody and use thereof |
| 08/26/2010 | WO2010094760A1 Cajanus extracts and glucosamine for inflammatory disorders |
| 08/26/2010 | WO2010094128A1 Tissue-engineered cartilage from continuous flow culture |
| 08/26/2010 | WO2010094068A1 Treatment of chronic inflammatory conditions |
| 08/26/2010 | WO2010045229A3 Protecting and repairing cartilage and musculoskeletal soft tissues |
| 08/26/2010 | US20100216886 Polymorphs of n2-(1,1'-biphenyl-4-ylcarbonyl)-n1-[2-(4-fluorophenyl)-1,1-dimethylethyl]-l-alpha-glutamine |
| 08/26/2010 | US20100216882 Aspirin-triggered lipid mediators |
| 08/26/2010 | US20100216871 Use of compounds having ccr antagonism |
| 08/26/2010 | US20100216832 Method for Assaying FTO (2-Oxoglutarate Dependent Oxygenase) Activity |
| 08/26/2010 | US20100216823 Spirocyclic Derivatives |
| 08/26/2010 | US20100216820 Thienopyrimidiones for treatment of inflammatory disorders and cancers |
| 08/26/2010 | US20100216819 Thiazolopyrimidines for Use in Therapy |